Tokyo Electron Device lifts FY2027 dividend forecast to ¥129 per share
Reuters2026/08/03 01:20- TEL management reported FY2027 Q1 net sales of JPY 60.3 billion, up 33.6% year on year; ordinary income rose 127.8% to JPY 3.9 billion.
- Net income increased 117.7% to JPY 2.6 billion; progress versus the first-half forecast reached 56.9% for sales, 95.6% for ordinary income.
- Orders received totaled JPY 99.7 billion, supported by stronger semiconductor demand, longer lead times, higher prices, advance ordering tied to AI-driven demand.
- First-half forecast was revised upward; full-year forecast was raised to reflect the higher first-half outlook, while the second-half view was left unchanged.
- Interim dividend forecast was lifted to JPY 60 a share from JPY 39; annual dividend forecast increased to JPY 129 from JPY 108.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations